Quick Answer
Acurx Pharmaceuticals, Inc. reported Operating Income Loss of -$8.09 million for the year ending 2025.
- Acurx Pharmaceuticals, Inc. showed an increase of +42.7% in Operating Income Loss from 2024 to 2025.
- This data is from Acurx Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: -$8.09 million | Fiscal year 2024: -$14.12 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: